Evidence map›Paper›PMID 33758193›Full record

ArticleNature communications2021

Canonical versus non-canonical transsynaptic signaling of neuroligin 3 tunes development of sociality in mice.

Tomoyuki Yoshida, Atsushi Yamagata, Ayako Imai, Juhyon Kim, Hironori Izumi, Shogo Nakashima, Tomoko Shiroshima, Asami Maeda, Shiho Iwasawa-Okamoto, Kenji Azechi and 16 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Alternative microexon splicing code for a four-amino acid peptide of PTPRD governs behavioral development.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  7. bioRxiv : the preprint server for biology · 2026
    Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 12 institutions in 2 countries.

Tomoyuki YoshidaDepartment of Molecular Neuroscience, Faculty of Medicine, University of Toyama, Toyama, Japan. toyoshid@med.u-toyama.ac.jp.ORCID 0000-0002-8476-3798
Atsushi YamagataRIKEN Center for Biosystems Dynamics Research, Kanagawa, Japan.
Ayako ImaiDepartment of Molecular Neuroscience, Faculty of Medicine, University of Toyama, Toyama, Japan.
Juhyon KimDivision of Bio-Information Engineering, Faculty of Engineering, University of Toyama, Toyama, Japan.
Hironori IzumiDepartment of Molecular Neuroscience, Faculty of Medicine, University of Toyama, Toyama, Japan.
Shogo NakashimaDepartment of System Emotional Science, Faculty of Medicine, University of Toyama, Toyama, Japan.
Tomoko ShiroshimaDepartment of Anatomy, Kitasato University School of Medicine, Kanagawa, Japan.
Asami MaedaResearch Institute for Diseases of Old Age, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Shiho Iwasawa-OkamotoDepartment of Molecular Neuroscience, Faculty of Medicine, University of Toyama, Toyama, Japan.
Kenji AzechiDepartment of Molecular Neuroscience, Faculty of Medicine, University of Toyama, Toyama, Japan.
Fumina OsakaCenter for Research and Education on Drug Discovery, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
Takashi SaitohCenter for Research and Education on Drug Discovery, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
Katsumi MaenakaCenter for Research and Education on Drug Discovery, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.ORCID 0000-0002-5459-521X
Takashi ShimadaSHIMADZU Bioscience Research Partnership, Innovation Center, Shimadzu Scientific Instruments, Bothell, WA, USA.
Yuko FukataDivision of Membrane Physiology, Department of Molecular and Cellular Physiology, National Institute for Physiological Sciences, National Institutes of Natural Sciences, Aichi, Japan.ORCID 0000-0001-7724-8643
Masaki FukataDivision of Membrane Physiology, Department of Molecular and Cellular Physiology, National Institute for Physiological Sciences, National Institutes of Natural Sciences, Aichi, Japan.ORCID 0000-0001-5200-9806
Jumpei MatsumotoResearch Center for Idling Brain Science, University of Toyama, Toyama, Japan.
Hisao NishijoResearch Center for Idling Brain Science, University of Toyama, Toyama, Japan.ORCID 0000-0002-4786-4610
Keizo TakaoResearch Center for Idling Brain Science, University of Toyama, Toyama, Japan.ORCID 0000-0002-4734-3583
Shinji TanakaDepartment of Cellular Neurobiology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Shigeo OkabeDepartment of Cellular Neurobiology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.ORCID 0000-0003-1216-8890
Katsuhiko TabuchiJST PRESTO, Saitama, Japan.ORCID 0000-0002-1673-4637
Takeshi UemuraInstitute for Biomedical Sciences, Interdisciplinary Cluster for Cutting Edge Research, Shinshu University, Nagano, Japan.ORCID 0000-0001-6000-4618
Masayoshi MishinaBrain Science Laboratory, Research Organization of Science and Technology, Ritsumeikan University, Shiga, Japan.
Hisashi MoriDepartment of Molecular Neuroscience, Faculty of Medicine, University of Toyama, Toyama, Japan.ORCID 0000-0001-9743-2456
Shuya FukaiDepartment of Chemistry, Graduate School of Science, Kyoto University, Kyoto, Japan. fukai@kuchem.kyoto-u.ac.jp.ORCID 0000-0002-1241-1443
University of Toyama · JPHokkaido University · JPNational Institutes of Natural Sciences · JPShinshu University · JPThe University of Tokyo · JPBioscience Research · USJuntendo University · JPKitasato University · JPKyoto University · JPRIKEN Center for Biosystems Dynamics Research · JPRitsumeikan University · JPToyo University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuroligin 3 (NLGN3) and neurexins (NRXNs) constitute a canonical transsynaptic cell-adhesion pair, which has been implicated in autism. In autism spectrum disorder (ASD) development of sociality can be impaired. However, the molecular mechanism underlying NLGN3-mediated social development is unclear. Here, we identify non-canonical interactions between NLGN3 and protein tyrosine phosphatase δ (PTPδ) splice variants, competing with NRXN binding. NLGN3-PTPδ complex structure revealed a splicing-dependent interaction mode and competition mechanism between PTPδ and NRXNs. Mice carrying a NLGN3 mutation that selectively impairs NLGN3-NRXN interaction show increased sociability, whereas mice where the NLGN3-PTPδ interaction is impaired exhibit impaired social behavior and enhanced motor learning, with imbalance in excitatory/inhibitory synaptic protein expressions, as reported in the Nlgn3 R451C autism model. At neuronal level, the autism-related Nlgn3 R451C mutation causes selective impairment in the non-canonical pathway. Our findings suggest that canonical and non-canonical NLGN3 pathways compete and regulate the development of sociality.

Indexed as

Amino Acid SequenceAnimalsAutism Spectrum DisorderBehavior Rating ScaleCalcium-Binding ProteinsCell Adhesion Molecules, NeuronalDisease Models, AnimalFemaleHEK293 CellsHumansMaleMembrane ProteinsMiceMice, KnockoutMice, TransgenicMutationCalcium-Binding ProteinsCell Adhesion Molecules, NeuronalMembrane ProteinsNerve Tissue ProteinsNeural Cell Adhesion Moleculesneuroligin 3Nrxn1 protein, mouseReceptor-Like Protein Tyrosine Phosphatases, Class 2Recombinant Proteins

Identifiers

PMID33758193
PMCPMC7988105
OpenAlexW3138727301

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.